Literature DB >> 3021211

Purification of human collagenases with a hydroxamic acid affinity column.

W M Moore, C A Spilburg.   

Abstract

Human collagenase has been isolated from skin fibroblasts and rheumatoid synovium by using an affinity matrix, prepared by coupling Pro-Leu-Gly-NHOH to agarose. Following the methodology described herein, the skin enzyme was isolated in two steps in 76% yield and the synovial enzyme was purified in three steps in 71% yield. Importantly, each enzyme hydrolyzed collagen into 3/4-1/4 cleavage fragments, indicating that a true collagenase had been isolated. The column was specific for the human enzyme since the collagenase from Clostridium histolyticum did not bind. The affinity ligand was designed according to the formalism proposed by Holmquist and Vallee [Holmquist, B., & Vallee, B. L. (1979) Proc. Natl. Acad. Sci. U.S.A. 76, 6216] that effective metalloenzyme inhibitors can be synthesized by coupling a suitable metal-coordinating group to a substrate analogue. In this case, the hydroxamic acid probably coordinates to the active-site metal and the Pro-Leu-Gly moiety is similar to the carboxyl side of the cleavage site of collagen, the enzyme's substrate. The IC50 for N-(benzyloxycarbonyl)-Pro-Leu-Gly-NHOH is 4 X 10(-5) M for both enzymes. The affinity chromatographic procedures described here should aid in future studies on vertebrate collagenases.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3021211     DOI: 10.1021/bi00366a031

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  16 in total

1.  Cloning and sequencing of a gene encoding a novel extracellular neutral proteinase from Streptomyces sp. strain C5 and expression of the gene in Streptomyces lividans 1326.

Authors:  J S Lampel; J S Aphale; K A Lampel; W R Strohl
Journal:  J Bacteriol       Date:  1992-05       Impact factor: 3.490

2.  cDNA cloning, bacterial expression, in vitro renaturation and affinity purification of the zinc endopeptidase astacin.

Authors:  S Reyda; E Jacob; R Zwilling; W Stöcker
Journal:  Biochem J       Date:  1999-12-15       Impact factor: 3.857

3.  Identification and characterization of a novel collagenase in Xenopus laevis: possible roles during frog development.

Authors:  M A Stolow; D D Bauzon; J Li; T Sedgwick; V C Liang; Q A Sang; Y B Shi
Journal:  Mol Biol Cell       Date:  1996-10       Impact factor: 4.138

4.  Selection of a histidine-containing inhibitor of gelatinases through deconvolution of combinatorial tetrapeptide libraries.

Authors:  G Ferry; J A Boutin; G Atassi; J L Fauchère; G C Tucker
Journal:  Mol Divers       Date:  1997       Impact factor: 2.943

5.  Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation.

Authors:  E B Springman; E L Angleton; H Birkedal-Hansen; H E Van Wart
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

6.  Fragments of human fibroblast collagenase. Purification and characterization.

Authors:  I M Clark; T E Cawston
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

7.  Fragmentation of human polymorphonuclear-leucocyte collagenase.

Authors:  V Knäuper; A Osthues; Y A DeClerck; K E Langley; J Bläser; H Tschesche
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

8.  Inhibition of bone resorption in vitro by selective inhibitors of gelatinase and collagenase.

Authors:  P A Hill; A J Docherty; K M Bottomley; J P O'Connell; J R Morphy; J J Reynolds; M C Meikle
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

9.  Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis.

Authors:  Linda Chung; Deendayal Dinakarpandian; Naoto Yoshida; Janelle L Lauer-Fields; Gregg B Fields; Robert Visse; Hideaki Nagase
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

10.  Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domain.

Authors:  A J Fosang; K Last; V Knäuper; P J Neame; G Murphy; T E Hardingham; H Tschesche; J A Hamilton
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.